Literature DB >> 9667077

Contribution of human hepatic cytochrome P450 isoforms to regioselective hydroxylation of steroid hormones.

T Niwa1, Y Yabusaki, K Honma, N Matsuo, K Tatsuta, F Ishibashi, M Katagiri.   

Abstract

1. Hydroxylation activities toward steroid hormones were determined for eleven forms of human hepatic cytochrome P450s expressed in yeast Saccharomyces cerevisiae cells. Microsomes were prepared from the yeast cells and assayed for their regioselectivity of hydroxylation toward progesterone, pregnenolone, dehydroepiandrosterone (DHEA) and oestrone. 2. 6 beta-Hydroxylation of progesterone was catalysed most efficiently by CYP3A4, followed by CYP2D6. CYP3A4 showed the highest progesterone 16 alpha-hydroxylation activity, followed by CYP1A1 and CYP2D6. 16 alpha-Hydroxylation of pregnenolone was catalysed efficiently by CYP1A1 and CYP3A4. Only CYP3A4 exhibited 16 alpha-hydroxylase activities toward DHEA and oestrone. 3. Addition of nifedipine, a typical substrate of CYP3A4, inhibited the 6 beta- and 16 alpha-hydroxylation of progesterone by CYP3A4. 4. These results suggest that CYP3A4 and CYP1A1 are responsible for the hydroxylation of these endogenous steroids, as well as xenobiotics, in human liver.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9667077     DOI: 10.1080/004982598239290

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  14 in total

Review 1.  Contributions of human enzymes in carcinogen metabolism.

Authors:  Slobodan Rendic; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2012-05-10       Impact factor: 3.739

Review 2.  Human Family 1-4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Arch Toxicol       Date:  2021-01-18       Impact factor: 5.153

3.  In vitro cytochrome P450-mediated metabolism of exemestane.

Authors:  Landry K Kamdem; David A Flockhart; Zeruesenay Desta
Journal:  Drug Metab Dispos       Date:  2010-09-28       Impact factor: 3.922

Review 4.  Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: A comprehensive review.

Authors:  Lina Schiffer; Lise Barnard; Elizabeth S Baranowski; Lorna C Gilligan; Angela E Taylor; Wiebke Arlt; Cedric H L Shackleton; Karl-Heinz Storbeck
Journal:  J Steroid Biochem Mol Biol       Date:  2019-07-27       Impact factor: 4.292

5.  Characterization of Maternal and Fetal CYP3A-Mediated Progesterone Metabolism.

Authors:  Sara K Quinney; Tara Benjamin; Xiaomei Zheng; Avinash S Patil
Journal:  Fetal Pediatr Pathol       Date:  2017-09-26       Impact factor: 0.958

Review 6.  Nuclear receptor PXR, transcriptional circuits and metabolic relevance.

Authors:  Chibueze A Ihunnah; Mengxi Jiang; Wen Xie
Journal:  Biochim Biophys Acta       Date:  2011-02-02

Review 7.  The pregnane X receptor: from bench to bedside.

Authors:  Xiaochao Ma; Jeffrey R Idle; Frank J Gonzalez
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-07       Impact factor: 4.481

8.  Phe120 contributes to the regiospecificity of cytochrome P450 2D6: mutation leads to the formation of a novel dextromethorphan metabolite.

Authors:  Jack U Flanagan; Jean-Didier Maréchal; Richard Ward; Carol A Kemp; Lesley A McLaughlin; Michael J Sutcliffe; Gordon C K Roberts; Mark J I Paine; C Roland Wolf
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

9.  Mechanism of 17α,20-Lyase and New Hydroxylation Reactions of Human Cytochrome P450 17A1: 18O LABELING AND OXYGEN SURROGATE EVIDENCE FOR A ROLE OF A PERFERRYL OXYGEN.

Authors:  Francis K Yoshimoto; Eric Gonzalez; Richard J Auchus; F Peter Guengerich
Journal:  J Biol Chem       Date:  2016-06-23       Impact factor: 5.157

10.  Studies of pharmacokinetic and pharmacodynamic properties of isoallopregnanolone in healthy women.

Authors:  Helena Hedström; Marie Bixo; Sigrid Nyberg; Olav Spigset; Elisabeth Zingmark; Torbjörn Bäckström
Journal:  Psychopharmacology (Berl)       Date:  2008-10-24       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.